102 related articles for article (PubMed ID: 11163757)
1. The C-terminus of human glutaminase L mediates association with PDZ domain-containing proteins.
Olalla L; Aledo JC; Bannenberg G; Márquez J
FEBS Lett; 2001 Jan; 488(3):116-22. PubMed ID: 11163757
[TBL] [Abstract][Full Text] [Related]
2. Overexpression, purification, and characterization of glutaminase-interacting protein, a PDZ-domain protein from human brain.
Aledo JC; Rosado A; Olalla L; Campos JA; Márquez J
Protein Expr Purif; 2001 Dec; 23(3):411-8. PubMed ID: 11722177
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the dystrophin-syntrophin interaction using the two-hybrid system in yeast.
Castelló A; Brochériou V; Chafey P; Kahn A; Gilgenkrantz H
FEBS Lett; 1996 Mar; 383(1-2):124-8. PubMed ID: 8612778
[TBL] [Abstract][Full Text] [Related]
4. Single-amino acid substitutions alter the specificity and affinity of PDZ domains for their ligands.
Gee SH; Quenneville S; Lombardo CR; Chabot J
Biochemistry; 2000 Nov; 39(47):14638-46. PubMed ID: 11087420
[TBL] [Abstract][Full Text] [Related]
5. Role of electrostatic interactions in PDZ domain ligand recognition.
Harris BZ; Lau FW; Fujii N; Guy RK; Lim WA
Biochemistry; 2003 Mar; 42(10):2797-805. PubMed ID: 12627945
[TBL] [Abstract][Full Text] [Related]
6. Cyclic peptides as non-carboxyl-terminal ligands of syntrophin PDZ domains.
Gee SH; Sekely SA; Lombardo C; Kurakin A; Froehner SC; Kay BK
J Biol Chem; 1998 Aug; 273(34):21980-7. PubMed ID: 9705339
[TBL] [Abstract][Full Text] [Related]
7. Promiscuous binding at the crossroads of numerous cancer pathways: insight from the binding of glutaminase interacting protein with glutaminase L.
Zoetewey DL; Ovee M; Banerjee M; Bhaskaran R; Mohanty S
Biochemistry; 2011 May; 50(17):3528-39. PubMed ID: 21417405
[TBL] [Abstract][Full Text] [Related]
8. Probing the structure and function of human glutaminase-interacting protein: a possible target for drug design.
Banerjee M; Huang C; Marquez J; Mohanty S
Biochemistry; 2008 Sep; 47(35):9208-19. PubMed ID: 18690705
[TBL] [Abstract][Full Text] [Related]
9. Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction.
Chen Z; Hague C; Hall RA; Minneman KP
J Biol Chem; 2006 May; 281(18):12414-20. PubMed ID: 16533813
[TBL] [Abstract][Full Text] [Related]
10. Energetic determinants of internal motif recognition by PDZ domains.
Harris BZ; Hillier BJ; Lim WA
Biochemistry; 2001 May; 40(20):5921-30. PubMed ID: 11352727
[TBL] [Abstract][Full Text] [Related]
11. TIP-1 has PDZ scaffold antagonist activity.
Alewine C; Olsen O; Wade JB; Welling PA
Mol Biol Cell; 2006 Oct; 17(10):4200-11. PubMed ID: 16855024
[TBL] [Abstract][Full Text] [Related]
12. Expression of the scaffolding PDZ protein glutaminase-interacting protein in mammalian brain.
Olalla L; Gutiérrez A; Jiménez AJ; López-Téllez JF; Khan ZU; Pérez J; Alonso FJ; de la Rosa V; Campos-Sandoval JA; Segura JA; Aledo JC; Márquez J
J Neurosci Res; 2008 Feb; 86(2):281-92. PubMed ID: 17847083
[TBL] [Abstract][Full Text] [Related]
13. Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels.
Schultz J; Hoffmüller U; Krause G; Ashurst J; Macias MJ; Schmieder P; Schneider-Mergener J; Oschkinat H
Nat Struct Biol; 1998 Jan; 5(1):19-24. PubMed ID: 9437424
[TBL] [Abstract][Full Text] [Related]
14. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex.
Hillier BJ; Christopherson KS; Prehoda KE; Bredt DS; Lim WA
Science; 1999 Apr; 284(5415):812-5. PubMed ID: 10221915
[TBL] [Abstract][Full Text] [Related]
15. In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4.
Adams ME; Mueller HA; Froehner SC
J Cell Biol; 2001 Oct; 155(1):113-22. PubMed ID: 11571312
[TBL] [Abstract][Full Text] [Related]
16. Specificity and promiscuity in human glutaminase interacting protein recognition: insight from the binding of the internal and C-terminal motif.
Banerjee M; Zoetewey DL; Ovee M; Mazumder S; Petrenko VA; Samoylova TI; Mohanty S
Biochemistry; 2012 Sep; 51(35):6950-60. PubMed ID: 22876914
[TBL] [Abstract][Full Text] [Related]
17. Identification of brain-specific angiogenesis inhibitor 2 as an interaction partner of glutaminase interacting protein.
Zencir S; Ovee M; Dobson MJ; Banerjee M; Topcu Z; Mohanty S
Biochem Biophys Res Commun; 2011 Aug; 411(4):792-7. PubMed ID: 21787750
[TBL] [Abstract][Full Text] [Related]
18. Full-length human glutaminase in complex with an allosteric inhibitor.
DeLaBarre B; Gross S; Fang C; Gao Y; Jha A; Jiang F; Song J J; Wei W; Hurov JB
Biochemistry; 2011 Dec; 50(50):10764-70. PubMed ID: 22049910
[TBL] [Abstract][Full Text] [Related]
19. A novel glutaminase isoform in mammalian tissues.
de la Rosa V; Campos-Sandoval JA; Martín-Rufián M; Cardona C; Matés JM; Segura JA; Alonso FJ; Márquez J
Neurochem Int; 2009; 55(1-3):76-84. PubMed ID: 19428810
[TBL] [Abstract][Full Text] [Related]
20. Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition.
Hasegawa M; Cuenda A; Spillantini MG; Thomas GM; Buée-Scherrer V; Cohen P; Goedert M
J Biol Chem; 1999 Apr; 274(18):12626-31. PubMed ID: 10212242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
